Assetmark, Inc Mannkind Corp Transaction History
Assetmark, Inc
- $45.6 Billion
- Q3 2025
A detailed history of Assetmark, Inc transactions in Mannkind Corp stock. As of the latest transaction made, Assetmark, Inc holds 532 shares of MNKD stock, worth $2,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
532
Previous 532
-0.0%
Holding current value
$2,995
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MNKD
# of Institutions
246Shares Held
161MCall Options Held
1.24MPut Options Held
183K-
Black Rock Inc. New York, NY22.6MShares$127 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$99.3 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$60.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$42.9 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$39.5 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.45B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...